{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:37:59Z","timestamp":1787240279636,"version":"build-2736575974"},"reference-count":266,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.pharmthera.2022.108316","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T16:27:23Z","timestamp":1669307243000},"page":"108316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Is the peroxisome proliferator-activated receptor gamma a putative target for epilepsy treatment? Current evidence and future perspectives"],"prefix":"10.1016","volume":"241","author":[{"given":"Lara","family":"Senn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Maria","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Avallone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Soca\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Wla\u017a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Biagini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2022.108316_bb0005","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.brainres.2010.06.034","article-title":"Anticonvulsant potential of the peroxisome proliferator-activated receptor gamma agonist pioglitazone in pentylenetetrazole-induced acute seizures and kindling in mice","volume":"1351","author":"Abdallah","year":"2010","journal-title":"Brain Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108316_bb0010","first-page":"749","article-title":"Increased expression of matrix metalloproteinase-9 in patients with temporal lobe epilepsy","volume":"25","author":"Acar","year":"2015","journal-title":"Turkish Neurosurgery"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108316_bb0015","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3390\/nu10040393","article-title":"Effects of dietary fatty acids in pancreatic beta cell metabolism, implications in homeostasis","volume":"10","author":"Acosta-Monta\u00f1o","year":"2018","journal-title":"Nutrients"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2022.108316_bb0020","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.eplepsyres.2012.02.015","article-title":"Possible involvement of PPAR-gamma receptor and nitric oxide pathway in the anticonvulsant effect of acute pioglitazone on pentylenetetrazole-induced seizures in mice","volume":"101","author":"Adabi Mohazab","year":"2012","journal-title":"Epilepsy Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108316_bb0025","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.bbrc.2016.08.043","article-title":"Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders","volume":"483","author":"Agarwal","year":"2017","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2022.108316_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2015.00466","article-title":"Correlation between IL-10 and microRNA-187 expression in epileptic rat hippocampus and patients with temporal lobe epilepsy","volume":"9","author":"Alsharafi","year":"2015","journal-title":"Frontiers in Cellular Neuroscience"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2022.108316_bb0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0014-2999(03)01867-3","article-title":"Neuroprotective effects of PPARgamma agonists against oxidative insults in HT-22 cells","volume":"472","author":"Aoun","year":"2003","journal-title":"European Journal of Pharmacology"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108316_bb0040","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.2337\/diab.46.8.1319","article-title":"Tissue distribution and quantification of the expression of mrnas of peroxisome proliferator\u2013activated receptors and liver X receptor-\u03b1 in humans: no alteration in adipose tissue of obese and NIDDM patients","volume":"46","author":"Auboeuf","year":"1997","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108316_bb0045","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.eplepsyres.2011.05.022","article-title":"Fatty acid oxidation and epilepsy","volume":"100","author":"Auvin","year":"2012","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.pharmthera.2022.108316_bb0050","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.imlet.2020.01.006","article-title":"Targeting PPAR ligands as possible approaches for metabolic reprogramming of T cells in cancer immunotherapy","volume":"220","author":"Bahrambeigi","year":"2020","journal-title":"Immunology Letters"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108316_bb0055","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1007\/s00213-018-4960-2","article-title":"Polymorphisms of peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) and cluster of differentiation 36 (CD36) associated with valproate-induced obesity in epileptic patients","volume":"235","author":"Bai","year":"2018","journal-title":"Psychopharmacology"},{"issue":"12","key":"10.1016\/j.pharmthera.2022.108316_bb0060","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1080\/14656566.2019.1617850","article-title":"Moving beyond sodium valproate: Choosing the right anti-epileptic drug in children","volume":"20","author":"Balagura","year":"2019","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108316_bb0065","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1111\/j.1476-5381.2012.01938.x","article-title":"Submaximal PPAR\u03b3 activation and endothelial dysfunction: New perspectives for the management of cardiovascular disorders","volume":"166","author":"Balakumar","year":"2012","journal-title":"British Journal of Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108316_bb0070","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12883-020-01825-x","article-title":"Chronically reduced IL-10 plasma levels are associated with hippocampal sclerosis in temporal lobe epilepsy patients","volume":"20","author":"Basnyat","year":"2020","journal-title":"BMC Neurology"},{"issue":"13","key":"10.1016\/j.pharmthera.2022.108316_bb0075","doi-asserted-by":"crossref","first-page":"9131","DOI":"10.1074\/jbc.275.13.9131","article-title":"Cloning and characterization of a functional peroxisome proliferator activator receptor-gamma-responsive element in the promoter of the CAP gene","volume":"275","author":"Baumann","year":"2000","journal-title":"The Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108316_bb0080","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0920-1211(01)00269-8","article-title":"Superoxide dismutase, glutathione peroxidase activities and the hydroperoxide concentration are modified in the hippocampus of epileptic rats","volume":"46","author":"Bellissimo","year":"2001","journal-title":"Epilepsy Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108316_bb0085","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.med.53.082901.104018","article-title":"The mechanisms of action of PPARs","volume":"53","author":"Berger","year":"2002","journal-title":"Annual Review of Medicine"},{"issue":"12","key":"10.1016\/j.pharmthera.2022.108316_bb0090","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1515\/hsz-2013-0152","article-title":"The nuclear receptor peroxisome proliferator-activated receptor-\u03b3 promotes oligodendrocyte differentiation through mechanisms involving mitochondria and oscillatory Ca 2+ waves","volume":"394","author":"Bernardo","year":"2013","journal-title":"Bchm"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108316_bb0095","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2174\/138161206780574579","article-title":"PPAR-&#947; Agonists as regulators of microglial activation and brain inflammation","volume":"12","author":"Bernardo","year":"2006","journal-title":"Current Pharmaceutical Design"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108316_bb0100","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1007\/s11064-013-1064-6","article-title":"Possible involvement of PPAR-\u03b3 in the anticonvulsant effect of aegle marmelos (L.) correa","volume":"38","author":"Bhatti","year":"2013","journal-title":"Neurochemical Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108316_bb0105","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1046\/j.1471-4159.2001.00163.x","article-title":"Brain-derived neurotrophic factor superinduction parallels anti-epileptic\u2212neuroprotective treatment in the pilocarpine epilepsy model: BDNF superinduction by anticonvulsants","volume":"76","author":"Biagini","year":"2001","journal-title":"Journal of Neurochemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108316_bb0110","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejphar.2011.08.020","article-title":"Beneficial effects of desacyl-ghrelin, hexarelin and EP-80317 in models of status epilepticus","volume":"670","author":"Biagini","year":"2011","journal-title":"European Journal of Pharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108316_bb0115","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0306-4522(01)00473-0","article-title":"Polyunsaturated fatty acids induce ischemic and epileptic tolerance","volume":"109","author":"Blondeau","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108316_bb0120","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neulet.2015.08.007","article-title":"Expression regulation and targeting of the peroxisome proliferator-activated receptor \u03b3 following electrically-induced status epilepticus","volume":"604","author":"Boes","year":"2015","journal-title":"Neuroscience Letters"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108316_bb0125","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10549-008-9944-1","article-title":"Peroxisome proliferator-activated receptor gamma activates fas ligand gene promoter inducing apoptosis in human breast cancer cells","volume":"113","author":"Bonofiglio","year":"2009","journal-title":"Breast Cancer Research and Treatment"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108316_bb0130","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.brainresbull.2005.01.004","article-title":"Microarray analysis of rat brain gene expression after chronic administration of sodium valproate","volume":"65","author":"Bosetti","year":"2005","journal-title":"Brain Research Bulletin"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108316_bb0135","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3390\/ijms19041197","article-title":"PPAR agonists and metabolic syndrome: An established role?","volume":"19","author":"Botta","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108316_bb0140","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1210\/endo.137.1.8536636","article-title":"Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat","volume":"137","author":"Braissant","year":"1996","journal-title":"Endocrinology"},{"issue":"37","key":"10.1016\/j.pharmthera.2022.108316_bb0145","doi-asserted-by":"crossref","first-page":"23786","DOI":"10.1074\/jbc.273.37.23786","article-title":"Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor \u03b1","volume":"273","author":"Brandt","year":"1998","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108316_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2008\/658520","article-title":"PPAR regulation of inflammatory signaling in CNS diseases","volume":"2008","author":"Bright","year":"2008","journal-title":"PPAR Research"},{"key":"10.1016\/j.pharmthera.2022.108316_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.172974","article-title":"Gabapentin attenuates intestinal inflammation: Role of PPAR-gamma receptor","volume":"873","author":"de Brito","year":"2020","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108316_bb0160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pneurobio.2017.10.002","article-title":"Peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3): A master gatekeeper in CNS injury and repair","volume":"163\u2013164","author":"Cai","year":"2018","journal-title":"Progress in Neurobiology"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108316_bb0165","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S1059-1311(00)90530-2","article-title":"Evolution of juvenile myoclonic epilepsy treated from the outset with sodium valproate","volume":"10","author":"Calleja","year":"2001","journal-title":"Seizure"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108316_bb0170","doi-asserted-by":"crossref","first-page":"18348","DOI":"10.3390\/ijms160818348","article-title":"Overview of Nrf2 as therapeutic target in epilepsy","volume":"16","author":"Carmona-Aparicio","year":"2015","journal-title":"International Journal of Molecular Sciences"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108316_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094733","article-title":"A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis","volume":"9","author":"Carrillo-Salinas","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108316_bb0180","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.eplepsyres.2014.03.001","article-title":"Structural changes in the temporal lobe and piriform cortex in frontal lobe epilepsy","volume":"108","author":"Centeno","year":"2014","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.pharmthera.2022.108316_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/352957","article-title":"The peroxisomal 3-keto-acyl-CoA thiolase B gene expression is under the dual control of PPAR\u03b1 and HNF4\u03b1 in the liver","volume":"2010","author":"Chamouton","year":"2010","journal-title":"PPAR Research"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108316_bb0190","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI11245","article-title":"Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones","volume":"106","author":"Chao","year":"2000","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2022.108316_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/479364","article-title":"Molecular and therapeutic potential and toxicity of valproic acid","volume":"2010","author":"Chateauvieux","year":"2010","journal-title":"Journal of Biomedicine and Biotechnology"},{"key":"10.1016\/j.pharmthera.2022.108316_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2013.03.018","article-title":"Mitochondrial diseases of the brain","volume":"63","author":"Chaturvedi","year":"2013","journal-title":"Free Radical Biology and Medicine"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108316_bb0205","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1111\/jcmm.14280","article-title":"PPAR\u03b3 inhibition regulates the cell cycle, proliferation and motility of bladder cancer cells","volume":"23","author":"Cheng","year":"2019","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108316_bb0210","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/cncr.27865","article-title":"CITED2 is a novel direct effector of peroxisome proliferator-activated receptor \u03b3 in suppressing hepatocellular carcinoma cell growth","volume":"119","author":"Cheung","year":"2013","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108316_bb0215","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1528-1167.2005.52704.x","article-title":"Cost-effectiveness of first-line antiepileptic drug treatments in the developing world: A population-level analysis","volume":"46","author":"Chisholm","year":"2005","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108316_bb0220","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1177\/0091270005279578","article-title":"Single- and multiple-dose pharmacokinetics of pioglitazone in adolescents with type 2 diabetes","volume":"45","author":"Christensen","year":"2005","journal-title":"Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108316_bb0225","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1186\/1742-2094-9-184","article-title":"Peroxisome proliferator-activated receptors \u03b3\/mitochondrial uncoupling protein 2 signaling protects against seizure-induced neuronal cell death in the hippocampus following experimental status epilepticus","volume":"9","author":"Chuang","year":"2012","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2022.108316_bb0230","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neuropharm.2012.11.017","article-title":"Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-\u03b1 receptor activation in a genetic model of absence epilepsy","volume":"69","author":"Citraro","year":"2013","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108316_bb0235","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s12035-014-8669-x","article-title":"Neuropeptides as targets for the development of anticonvulsant drugs","volume":"50","author":"Clynen","year":"2014","journal-title":"Molecular Neurobiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108316_bb0240","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","article-title":"Microglia function in the central nervous system during health and neurodegeneration","volume":"35","author":"Colonna","year":"2017","journal-title":"Annual Review of Immunology"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108316_bb0245","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1523\/JNEUROSCI.20-02-00558.2000","article-title":"Inflammatory mechanisms in Alzheimer\u2019s disease: Inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists","volume":"20","author":"Combs","year":"2000","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108316_bb0250","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3390\/jpm12040527","article-title":"Prospective evaluation of ghrelin and des-acyl ghrelin plasma levels in children with newly diagnosed epilepsy: Evidence for reduced ghrelin-to-des-acyl ghrelin ratio in generalized epilepsies","volume":"12","author":"Costa","year":"2022","journal-title":"Journal of Personalized Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108316_bb0255","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.3390\/nu13041240","article-title":"Evaluation of E-health applications for paediatric patients with refractory epilepsy and maintained on ketogenic diet","volume":"13","author":"Costa","year":"2021","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108316_bb0260","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3390\/ph15050495","article-title":"Antiseizure effects of cannabidiol leading to increased peroxisome proliferator-activated receptor gamma levels in the hippocampal CA3 subfield of epileptic rats","volume":"15","author":"Costa","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.pharmthera.2022.108316_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/409168","article-title":"PPARG: Gene expression regulation and next-generation sequencing for unsolved issues","volume":"2010","author":"Costa","year":"2010","journal-title":"PPAR Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108316_bb0270","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1528-1157.1999.tb05561.x","article-title":"New antiepileptic drugs: Comparison of key clinical trials","volume":"40","author":"Cramer","year":"1999","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108316_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117973","article-title":"Effects of low doses of pioglitazone on resting-state functional connectivity in conscious rat brain","volume":"10","author":"Crenshaw","year":"2015","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.pharmthera.2022.108316_bb0280","doi-asserted-by":"crossref","first-page":"9775","DOI":"10.3390\/ijms22189775","article-title":"The regulatory roles of ppars in skeletal muscle fuel metabolism and inflammation: Impact of PPAR agonism on muscle in chronic disease, contraction and sepsis","volume":"22","author":"Crossland","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108316_bb0285","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1053\/meta.2001.24870","article-title":"Peroxisome proliferator-activated receptor subtype-specific regulation of hepatic and peripheral gene expression in the Zucker diabetic fatty rat","volume":"50","author":"Dana","year":"2001","journal-title":"Metabolism, Clinical and Experimental"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108316_bb0290","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/hipo.10190","article-title":"Ontogeny of seizure-induced increases in BDNF immunoreactivity and TrkB receptor activation in rat hippocampus","volume":"14","author":"Danzer","year":"2004","journal-title":"Hippocampus"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2022.108316_bb0295","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbalip.2004.11.017","article-title":"Expression of cFABP and PPAR in trophoblast cells: Effect of PPAR ligands on linoleic acid uptake and differentiation","volume":"1687","author":"Daoud","year":"2005","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108316_bb0300","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2174\/1567202619666211217140954","article-title":"Combination of peroxisome proliferator-activated receptor gamma (PPAR\u03b3) agonist and PPAR gamma co-activator 1\u03b1 (PGC-1\u03b1) ActivatorAmeliorates cognitive deficits, oxidative stress, and inflammation in rodent model of Parkinson\u2019s disease","volume":"18","author":"Das","year":"2021","journal-title":"Current Neurovascular Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108316_bb0305","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1528-1157.1988.tb04409.x","article-title":"Valproate monotherapy in 30 patients with partial seizures","volume":"29","author":"Dean","year":"1988","journal-title":"Epilepsia"},{"issue":"47","key":"10.1016\/j.pharmthera.2022.108316_bb0310","doi-asserted-by":"crossref","first-page":"16725","DOI":"10.1523\/JNEUROSCI.2153-12.2012","article-title":"Cognitive enhancement with rosiglitazone links the hippocampal PPAR and ERK MAPK signaling pathways","volume":"32","author":"Denner","year":"2012","journal-title":"Journal of Neuroscience"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108316_bb0315","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.tins.2012.11.008","article-title":"Glia and epilepsy: Excitability and inflammation","volume":"36","author":"Devinsky","year":"2013","journal-title":"Trends in Neurosciences"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108316_bb0320","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/nm.2421","article-title":"Peroxisome proliferation\u2013associated control of reactive oxygen species sets melanocortin tone and feeding in diet-induced obesity","volume":"17","author":"Diano","year":"2011","journal-title":"Nature Medicine"},{"issue":"11","key":"10.1016\/j.pharmthera.2022.108316_bb0325","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.1210\/en.2003-0667","article-title":"Uncoupling protein 2 prevents neuronal death including that occurring during seizures: A mechanism for preconditioning","volume":"144","author":"Diano","year":"2003","journal-title":"Endocrinology"},{"issue":"40","key":"10.1016\/j.pharmthera.2022.108316_bb0330","doi-asserted-by":"crossref","first-page":"10674","DOI":"10.1523\/JNEUROSCI.2001-07.2007","article-title":"Enhanced astrocytic Ca2+ signals contribute to neuronal excitotoxicity after status epilepticus","volume":"27","author":"Ding","year":"2007","journal-title":"Journal of Neuroscience"},{"issue":"16","key":"10.1016\/j.pharmthera.2022.108316_bb0335","doi-asserted-by":"crossref","first-page":"10819","DOI":"10.1073\/pnas.152334899","article-title":"Brain monoglyceride lipase participating in endocannabinoid inactivation","volume":"99","author":"Dinh","year":"2002","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108316_bb0340","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1046\/j.1528-1157.2003.07203.x","article-title":"Voltage-dependent block of N-methyl-D-aspartate receptors by the novel anticonvulsant dibenzylamine, a bioactive constituent of L-(+)-beta-hydroxybutyrate","volume":"44","author":"Donevan","year":"2003","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.pharmthera.2022.108316_bb0345","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/j.bbadis.2013.07.008","article-title":"Glutathione and antioxidant enzymes serve complementary roles in protecting activated hepatic stellate cells against hydrogen peroxide-induced cell death","volume":"1832","author":"Dunning","year":"2013","journal-title":"Biochimica et Biophysica Acta"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108316_bb0350","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1111\/epi.13038","article-title":"Ketogenic diet exhibits anti-inflammatory properties","volume":"56","author":"Dupuis","year":"2015","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108316_bb0355","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1600-0404.2006.00592.x","article-title":"Serum Fas and Bcl-2 in patients with epilepsy","volume":"113","author":"El-Hodhod","year":"2006","journal-title":"Acta Neurologica Scandinavica"},{"issue":"14","key":"10.1016\/j.pharmthera.2022.108316_bb0360","doi-asserted-by":"crossref","first-page":"8711","DOI":"10.1074\/jbc.M114.618447","article-title":"Fatty acid-binding proteins (FABPs) are intracellular carriers for \u03949-tetrahydrocannabinol (THC) and cannabidiol (CBD)","volume":"290","author":"Elmes","year":"2015","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108316_bb0365","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0920-1211(96)00043-5","article-title":"Introduction to temporal lobe epilepsy","volume":"26","author":"Engel","year":"1996","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.pharmthera.2022.108316_bb0370","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neulet.2013.10.057","article-title":"Protective effect of telmisartan against oxidative damage induced by high glucose in neuronal PC12 cell","volume":"558","author":"Eslami","year":"2014","journal-title":"Neuroscience Letters"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108316_bb0375","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.bjp.0707337","article-title":"Cannabidiol in vivo blunts \u03b2-amyloid induced neuroinflammation by suppressing IL-1\u03b2 and iNOS expression: CBD blunts A \u03b2 induced neuroinflammation in vivo","volume":"151","author":"Esposito","year":"2007","journal-title":"British Journal of Pharmacology"},{"issue":"12","key":"10.1016\/j.pharmthera.2022.108316_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028668","article-title":"Cannabidiol reduces A\u03b2-induced neuroinflammation and promotes hippocampal neurogenesis through PPAR\u03b3 involvement","volume":"6","author":"Esposito","year":"2011","journal-title":"PLoS One"},{"issue":"30","key":"10.1016\/j.pharmthera.2022.108316_bb0385","doi-asserted-by":"crossref","first-page":"18779","DOI":"10.1074\/jbc.272.30.18779","article-title":"The organization, promoter analysis, and expression of the human PPARgamma gene","volume":"272","author":"Fajas","year":"1997","journal-title":"The Journal of Biological Chemistry"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2022.108316_bb0390","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-5793(98)01273-3","article-title":"PPARgamma3 mRNA: A distinct PPARgamma mRNA subtype transcribed from an independent promoter","volume":"438","author":"Fajas","year":"1998","journal-title":"FEBS Letters"},{"key":"10.1016\/j.pharmthera.2022.108316_bb0395","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.omtm.2018.03.001","article-title":"Seizure-suppressant and neuroprotective effects of encapsulated BDNF-producing cells in a rat model of temporal lobe epilepsy","volume":"9","author":"Falcicchia","year":"2018","journal-title":"Molecular Therapy - Methods & Clinical Development"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108316_bb0400","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0006-291X(02)02983-2","article-title":"Activation of PPARgamma increases PTEN expression in pancreatic cancer cells","volume":"301","author":"Farrow","year":"2003","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108316_bb0405","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.plipres.2005.12.002","article-title":"From molecular action to physiological outputs: Peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions","volume":"45","author":"Feige","year":"2006","journal-title":"Progress in Lipid Research"},{"issue":"11","key":"10.1016\/j.pharmthera.2022.108316_bb0410","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S1474-4422(17)30299-5","article-title":"Global, regional, and national burden of neurological disorders during 1990\u20132015: A systematic analysis for the Global Burden of Disease Study 2015","volume":"16","author":"Feigin","year":"2017","journal-title":"The Lancet Neurology"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108316_bb0415","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.0013-9580.2005.66104.x","article-title":"Epileptic seizures and epilepsy: Definitions proposed by the international league against epilepsy (ILAE) and the international bureau for epilepsy (IBE)","volume":"46","author":"Fisher","year":"2005","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108316_bb0420","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/1097-4652(200010)185:1<80::AID-JCP7>3.0.CO;2-W","article-title":"Role of heme oxygenase-1 in the regulation of manganese superoxide dismutase gene expression in oxidatively-challenged astroglia","volume":"185","author":"Frankel","year":"2000","journal-title":"Journal of Cellular Physiology"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108316_bb0425","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/archpedi.153.9.946","article-title":"Seizures decrease rapidly after fasting: Preliminary studies of the ketogenic diet","volume":"153","author":"Freeman","year":"1999","journal-title":"Archives of Pediatrics & Adolescent Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108316_bb0430","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12974-018-1060-5","article-title":"Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson\u2019s disease: Possible involvement of different binding sites at the PPAR\u03b3 receptor","volume":"15","author":"Garc\u00eda","year":"2018","journal-title":"Journal of Neuroinflammation"},{"issue":"25","key":"10.1016\/j.pharmthera.2022.108316_bb0435","doi-asserted-by":"crossref","first-page":"24143","DOI":"10.1074\/jbc.M502649200","article-title":"Promoter rearrangements cause species-specific hepatic regulation of the glyoxylate reductase\/hydroxypyruvate reductase gene by the peroxisome proliferator-activated receptor alpha","volume":"280","author":"Genolet","year":"2005","journal-title":"The Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108316_bb0440","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2337\/diab.46.3.433","article-title":"Cardiac and glycemic benefits of troglitazone treatment in NIDDM","volume":"46","author":"Ghazzi","year":"1997","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108316_bb0445","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molcel.2006.11.022","article-title":"Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPAR\u03b3","volume":"25","author":"Ghisletti","year":"2007","journal-title":"Molecular Cell"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108316_bb0450","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1600-0404.2008.01097.x","article-title":"Treatment of status epilepticus and acute repetitive seizures with i.v. Valproic acid vs phenytoin","volume":"118","author":"Gilad","year":"2008","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1016\/j.pharmthera.2022.108316_bb0455","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2016.00281","article-title":"Progressive seizure aggravation in the repeated 6-Hz Corneal stimulation model is accompanied by marked increase in hippocampal p-ERK1\/2 immunoreactivity in neurons","volume":"10","author":"Giordano","year":"2016","journal-title":"Frontiers in Cellular Neuroscience"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108316_bb0460","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/epi.12074","article-title":"Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes","volume":"54","author":"Glauser","year":"2013","journal-title":"Epilepsia"},{"issue":"17","key":"10.1016\/j.pharmthera.2022.108316_bb0465","doi-asserted-by":"crossref","first-page":"9248","DOI":"10.3390\/ijms22179248","article-title":"The PPARg system in major depression: pathophysiologic and therapeutic implications","volume":"22","author":"Gold","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108316_bb0470","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.atherosclerosis.2004.12.028","article-title":"The PPAR\u03b4 agonist GW0742X reduces atherosclerosis in LDLR\u2212\/\u2212 mice","volume":"181","author":"Graham","year":"2005","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108316_bb0475","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nm780","article-title":"A futile metabolic cycle activated in adipocytes by antidiabetic agents","volume":"8","author":"Guan","year":"2002","journal-title":"Nature Medicine"},{"issue":"23","key":"10.1016\/j.pharmthera.2022.108316_bb0480","doi-asserted-by":"crossref","first-page":"11012","DOI":"10.1073\/pnas.91.23.11012","article-title":"The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression","volume":"91","author":"Gulick","year":"1994","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"4 Pt 1","key":"10.1016\/j.pharmthera.2022.108316_bb0485","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/clinchem\/28.4.642","article-title":"Monitoring octanoic and decanoic acids in plasma from children with intractable epilepsy treated with medium-chain triglyceride diet","volume":"28","author":"Haidukewych","year":"1982","journal-title":"Clinical Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108316_bb0490","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.biopha.2018.04.014","article-title":"Hispidulin inhibits hepatocellular carcinoma growth and metastasis through AMPK and ERK signaling mediated activation of PPAR\u03b3","volume":"103","author":"Han","year":"2018","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108316_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.112437","article-title":"TRIM27-mediated ubiquitination of PPAR\u03b3 promotes glutamate-induced cell apoptosis and inflammation","volume":"400","author":"Hao","year":"2021","journal-title":"Experimental Cell Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108316_bb0500","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1471-4159.2003.01694.x","article-title":"Noradrenergic depletion increases inflammatory responses in brain: Effects on IkappaB and HSP70 expression","volume":"85","author":"Heneka","year":"2003","journal-title":"Journal of Neurochemistry"},{"issue":"18","key":"10.1016\/j.pharmthera.2022.108316_bb0505","doi-asserted-by":"crossref","first-page":"6862","DOI":"10.1523\/JNEUROSCI.20-18-06862.2000","article-title":"Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo","volume":"20","author":"Heneka","year":"2000","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108316_bb0510","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.bbalip.2007.04.016","article-title":"PPARs in the brain","volume":"1771","author":"Heneka","year":"2007","journal-title":"Biochimica et Biophysica Acta"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108316_bb0515","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/thorax.58.9.778","article-title":"Inhibition of MMP-9 expression by PPARgamma activators in human bronchial epithelial cells","volume":"58","author":"Hetzel","year":"2003","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108316_bb0520","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/bph.13368","article-title":"Cannabidiol protects an in vitro model of the blood-brain barrier from oxygen-glucose deprivation via PPAR\u03b3 and 5-HT 1A receptors: CBD modulates BBB permeability","volume":"173","author":"Hind","year":"2016","journal-title":"British Journal of Pharmacology"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2022.108316_bb0525","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.brainresrev.2009.10.003","article-title":"The cytosolic redox state of astrocytes: Maintenance, regulation and functional implications for metabolite trafficking","volume":"63","author":"Hirrlinger","year":"2010","journal-title":"Brain Research Reviews"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108316_bb0530","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.neuint.2013.07.010","article-title":"The PPAR\u03b3 agonist rosiglitazone prevents neuronal loss and attenuates development of spontaneous recurrent seizures through BDNF\/TrkB signaling following pilocarpine-induced status epilepticus","volume":"63","author":"Hong","year":"2013","journal-title":"Neurochemistry International"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108316_bb0535","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10072-011-0774-2","article-title":"The PPAR\u03b3 agonist rosiglitazone prevents cognitive impairment by inhibiting astrocyte activation and oxidative stress following pilocarpine-induced status epilepticus","volume":"33","author":"Hong","year":"2012","journal-title":"Neurological Sciences"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108316_bb0540","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/0006-2952(85)90670-7","article-title":"Enhancement of peroxisomal \u03b2-oxidation in the liver of rats and mice treated with valproic acid","volume":"34","author":"Horie","year":"1985","journal-title":"Biochemical Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108316_bb0545","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/cvr\/cvn264","article-title":"PARP-1 suppresses adiponectin expression through poly(ADP-ribosyl)ation of PPAR gamma in cardiac fibroblasts","volume":"81","author":"Huang","year":"2009","journal-title":"Cardiovascular Research"},{"issue":"19","key":"10.1016\/j.pharmthera.2022.108316_bb0550","doi-asserted-by":"crossref","first-page":"7247","DOI":"10.3390\/ijms21197247","article-title":"Peroxisome proliferator-activated receptor \u03b3 coactivator 1\u03b1 activates vascular endothelial growth factor that protects against neuronal cell death following status epilepticus through PI3K\/AKT and MEK\/ERK signaling","volume":"21","author":"Huang","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108316_bb0555","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/jnc.12646","article-title":"The ketogenic diet component decanoic acid increases mitochondrial citrate synthase and complex I activity in neuronal cells","volume":"129","author":"Hughes","year":"2014","journal-title":"Journal of Neurochemistry"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108316_bb0560","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1007\/s12035-018-1457-2","article-title":"The protective role of peroxisome proliferator-activated receptor-gamma in seizure and neuronal excitotoxicity","volume":"56","author":"Hung","year":"2019","journal-title":"Molecular Neurobiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108316_bb0565","article-title":"Anticonvulsant and ameliorative effects of pioglitazone on cognitive deficits, inflammation and apoptosis in the hippocampus of rat pups exposed to febrile seizure","volume":"22","author":"Hussein","year":"2019","journal-title":"Iranian Journal of Basic Medical Sciences"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108316_bb0570","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s13311-015-0377-3","article-title":"Molecular targets of cannabidiol in neurological disorders","volume":"12","author":"Ibeas Bih","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108316_bb0575","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/jcbfm.1989.116","article-title":"Seizure-induced damage to substantia nigra and globus pallidus is accompanied by pronounced intra- and extracellular acidosis","volume":"9","author":"Inamura","year":"1989","journal-title":"Journal of Cerebral Blood Flow & Metabolism"},{"issue":"6294","key":"10.1016\/j.pharmthera.2022.108316_bb0580","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/347645a0","article-title":"Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators","volume":"347","author":"Issemann","year":"1990","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108316_bb0585","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.expneurol.2011.09.001","article-title":"Ketogenic diet-induced peroxisome proliferator-activated receptor-\u03b3 activation decreases neuroinflammation in the mouse hippocampus after kainic acid-induced seizures","volume":"232","author":"Jeong","year":"2011","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2022.108316_bb0590","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.794856","article-title":"Sodium valproate combined with topiramate vs. sodium valproate alone for refractory epilepsy: A systematic review and meta-analysis","volume":"12","author":"Ji","year":"2022","journal-title":"Frontiers in Neurology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108316_bb0595","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030406","article-title":"Metabolic state determines sensitivity to cellular stress in huntington disease: normalization by activation of PPAR\u03b3","volume":"7","author":"Jin","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108316_bb0600","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bbrc.2005.11.177","article-title":"Rosiglitazone protects human neuroblastoma SH-SY5Y cells against acetaldehyde-induced cytotoxicity","volume":"340","author":"Jung","year":"2006","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2022.108316_bb0605","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jns.2006.11.020","article-title":"Rosiglitazone protects human neuroblastoma SH-SY5Y cells against MPP+ induced cytotoxicity via inhibition of mitochondrial dysfunction and ROS production","volume":"253","author":"Jung","year":"2007","journal-title":"Journal of the Neurological Sciences"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108316_bb0610","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1528-1167.2008.01736.x","article-title":"Periictal diffusion abnormalities of the thalamus in partial status epilepticus: DWI Thalamic Lesions in Partial SE","volume":"50","author":"Katramados","year":"2009","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.pharmthera.2022.108316_bb0615","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1096\/fj.01-0147com","article-title":"The peroxisome proliferator-activated receptor alpha regulates amino acid metabolism","volume":"15","author":"Kersten","year":"2001","journal-title":"FASEB Journal\u202f: Official Publication of the Federation of American Societies for Experimental Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108316_bb0620","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1471-4159.2010.06728.x","article-title":"Ketones prevent synaptic dysfunction induced by mitochondrial respiratory complex inhibitors","volume":"114","author":"Kim","year":"2010","journal-title":"Journal of Neurochemistry"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108316_bb0625","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ijc.1470","article-title":"PPARgamma agonists inhibit cell growth and suppress the expression of cyclin D1 and EGF-like growth factors in ras-transformed rat intestinal epithelial cells","volume":"94","author":"Kitamura","year":"2001","journal-title":"International Journal of Cancer"},{"issue":"6389","key":"10.1016\/j.pharmthera.2022.108316_bb0630","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/358771a0","article-title":"Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors","volume":"358","author":"Kliewer","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2022.108316_bb0635","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.trci.2019.05.004","article-title":"Effects of pioglitazone on mnemonic hippocampal function: A blood oxygen level-dependent functional magnetic resonance imaging study in elderly adults","volume":"5","author":"Knodt","year":"2019","journal-title":"Alzheimer\u2019s & Dementia (New York, N. Y.)"},{"key":"10.1016\/j.pharmthera.2022.108316_bb0640","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.eplepsyres.2018.09.009","article-title":"Ketogenic diet regulates the antioxidant catalase via the transcription factor PPAR\u03b32","volume":"147","author":"Knowles","year":"2018","journal-title":"Epilepsy Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108316_bb0645","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1528-1167.2007.01417.x","article-title":"When do seizures usually improve with the ketogenic diet?","volume":"49","author":"Kossoff","year":"2008","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108316_bb0650","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.nurt.2009.01.005","article-title":"Ketogenic diets: Evidence for short- and long-term efficacy","volume":"6","author":"Kossoff","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pharmthera.2022.108316_bb0655","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/816856","article-title":"Review of the structural and dynamic mechanisms of PPAR \u03b3 partial agonism","volume":"2015","author":"Kroker","year":"2015","journal-title":"PPAR Research"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108316_bb0660","doi-asserted-by":"crossref","first-page":"E1502","DOI":"10.3390\/ijms18071502","article-title":"Mitochondrial dysfunction mediated by poly(ADP-Ribose) polymerase-1 activation contributes to hippocampal neuronal damage following status epilepticus","volume":"18","author":"Lai","year":"2017","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108316_bb0665","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1006\/taap.1999.8770","article-title":"New molecular bioassays for the estimation of the teratogenic potency of valproic acid derivatives in vitro: activation of the peroxisomal proliferator-activated receptor (PPAR\u03b4)","volume":"160","author":"Lampen","year":"1999","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108316_bb0670","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12031-008-9056-8","article-title":"Neuronal peroxisome proliferator-activated receptor \u03b3 signaling: Regulation by mood-stabilizer valproate","volume":"35","author":"Lan","year":"2008","journal-title":"Journal of Molecular Neuroscience"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108316_bb0675","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.expneurol.2006.04.006","article-title":"PPAR\u03b3 agonists as new therapeutic agents for the treatment of Alzheimer\u2019s disease","volume":"199","author":"Landreth","year":"2006","journal-title":"Experimental Neurology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108316_bb0680","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4062\/biomolther.2014.146","article-title":"Effect of pioglitazone on excitotoxic neuronal damage in the mouse hippocampus","volume":"23","author":"Lee","year":"2015","journal-title":"Biomolecules & Therapeutics"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108316_bb0685","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.toxlet.2012.07.016","article-title":"Rosiglitazone, a PPAR-\u03b3 agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats","volume":"213","author":"Lee","year":"2012","journal-title":"Toxicology Letters"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108316_bb0690","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/FJC.0b013e318062153b","article-title":"PPAR activation: A new target for the treatment of hypertension","volume":"50","author":"Leibovitz","year":"2007","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108316_bb0695","first-page":"6578","article-title":"Peroxisome proliferator-activated receptor-\u03b3 agonist-mediated inhibition of cell growth is independent of apoptosis in human epidermoid carcinoma A431 cells","volume":"15","author":"Li","year":"2018","journal-title":"Oncology Letters"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2022.108316_bb0700","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/biof.5520080107","article-title":"Neuroprotective versus neurodestructive effects of NO-related species","volume":"8","author":"Lipton","year":"1998","journal-title":"BioFactors"},{"key":"10.1016\/j.pharmthera.2022.108316_bb0705","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3389\/fphar.2017.00676","article-title":"Involvement of PPAR\u03b3 in the anticonvulsant activity of EP-80317, a ghrelin receptor antagonist","volume":"8","author":"Lucchi","year":"2017","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108316_bb0710","first-page":"29","article-title":"Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys","volume":"47","author":"Maeshiba","year":"1997","journal-title":"Arzneimittel-Forschung"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108316_bb0715","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0149-2918(00)83060-X","article-title":"Rosiglitazone in the treatment of type 2 diabetes mellitus: A critical review","volume":"22","author":"Malinowski","year":"2000","journal-title":"Clinical Therapeutics"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108316_bb0720","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s00018-007-7006-1","article-title":"Glycogen synthase 2 is a novel target gene of peroxisome proliferator-activated receptors","volume":"64","author":"Mandard","year":"2007","journal-title":"Cellular and Molecular Life Sciences: CMLS"},{"key":"10.1016\/j.pharmthera.2022.108316_bb0725","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/S0021-9150(97)00315-8","article-title":"PPAR\u03b3 activators improve glucose homeostasis by stimulating fatty acid uptake in the adipocytes","volume":"137","author":"Martin","year":"1998","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108316_bb0730","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.expneurol.2012.02.017","article-title":"Pharmacological manipulation of peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) reveals a role for anti-oxidant protection in a model of Parkinson\u2019s disease","volume":"235","author":"Martin","year":"2012","journal-title":"Experimental Neurology"},{"issue":"21","key":"10.1016\/j.pharmthera.2022.108316_bb0735","doi-asserted-by":"crossref","first-page":"11939","DOI":"10.3390\/ijms222111939","article-title":"The antioxidant transcription factor Nrf2 in cardiac ischemia-reperfusion injury","volume":"22","author":"Mata","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"3615","key":"10.1016\/j.pharmthera.2022.108316_bb0740","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1126\/science.144.3615.193","article-title":"Cellular mechanisms in experimental epileptic seizures","volume":"144","author":"Matsumoto","year":"1964","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108316_bb0745","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM198507183130303","article-title":"Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic\u2013clonic seizures","volume":"313","author":"Mattson","year":"1985","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108316_bb0750","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.biopha.2007.10.014","article-title":"The PPAR\u03b3 agonist FMOC-l-leucine protects both mature and immature brain","volume":"62","author":"Maurois","year":"2008","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108316_bb0755","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.pathophys.2015.06.002","article-title":"The influence of ovariectomy on anti-convulsant effect of pioglitazone in mice","volume":"22","author":"Moezi","year":"2015","journal-title":"Pathophysiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108316_bb0760","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1210\/endo-108-1-31","article-title":"Design, synthesis, and biological activity of peptides which release growth hormone in vitro*","volume":"108","author":"Momany","year":"1981","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2022.108316_bb0765","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neuroscience.2021.10.029","article-title":"Brain expression, physiological regulation and role in motivation and associative learning of peroxisome proliferator-activated receptor \u03b3","volume":"479","author":"Moosecker","year":"2021","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108316_bb0770","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0955-0674(98)80015-X","article-title":"The nuclear receptor ligand-binding domain: Structure and function","volume":"10","author":"Moras","year":"1998","journal-title":"Current Opinion in Cell Biology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108316_bb0775","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.braindev.2020.10.011","article-title":"Novel ACOX1 mutations in two siblings with peroxisomal acyl-CoA oxidase deficiency","volume":"43","author":"Morita","year":"2021","journal-title":"Brain & Development"},{"issue":"24","key":"10.1016\/j.pharmthera.2022.108316_bb0780","doi-asserted-by":"crossref","first-page":"17088","DOI":"10.1074\/jbc.274.24.17088","article-title":"Role of PPARgamma in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18(INK4c) and p21(Waf1\/Cip1), during adipogenesis","volume":"274","author":"Morrison","year":"1999","journal-title":"The Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108316_bb0785","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cmet.2014.03.027","article-title":"Transcriptional coregulators: Fine-tuning metabolism","volume":"20","author":"Mouchiroud","year":"2014","journal-title":"Cell Metabolism"},{"issue":"17","key":"10.1016\/j.pharmthera.2022.108316_bb0790","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1097\/00001756-199411000-00029","article-title":"Nitric oxide promotes seizure activity in kainate-treated rats","volume":"5","author":"M\u00fclsch","year":"1994","journal-title":"Neuroreport"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108316_bb0795","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.taap.2007.06.003","article-title":"Mitochondrial impairment by PPAR agonists and statins identified via immunocaptured OXPHOS complex activities and respiration","volume":"223","author":"Nadanaciva","year":"2007","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108316_bb0800","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1128\/MCB.26.8.3266-3281.2006","article-title":"Differentiation of trophoblast giant cells and their metabolic functions are dependent on peroxisome proliferator-activated receptor beta\/delta","volume":"26","author":"Nadra","year":"2006","journal-title":"Molecular and Cellular Biology"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108316_bb0805","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/j.1528-1167.2008.01870.x","article-title":"A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy","volume":"50","author":"Neal","year":"2009","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108316_bb0810","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1007\/s00125-012-2538-9","article-title":"Pioglitazone and risk of bladder cancer among diabetic patients in France: A population-based cohort study","volume":"55","author":"Neumann","year":"2012","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108316_bb0815","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.yebeh.2010.07.011","article-title":"Vascular endothelial growth factor attenuates status epilepticus-induced behavioral impairments in rats","volume":"19","author":"Nicoletti","year":"2010","journal-title":"Epilepsy & Behavior"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108316_bb0820","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040535","article-title":"VEGF receptor-2 (Flk-1) overexpression in mice counteracts focal epileptic seizures","volume":"7","author":"Nikitidou","year":"2012","journal-title":"PLoS One"},{"issue":"24","key":"10.1016\/j.pharmthera.2022.108316_bb0825","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa072761","article-title":"Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes","volume":"356","author":"Nissen","year":"2007","journal-title":"New England Journal of Medicine"},{"issue":"6698","key":"10.1016\/j.pharmthera.2022.108316_bb0830","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/25931","article-title":"Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-\u03b3","volume":"395","author":"Nolte","year":"1998","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108316_bb0835","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1023\/A:1020696321609","article-title":"Troglitazone improves cardiac function in patients with congestive heart failure","volume":"16","author":"Ogino","year":"2002","journal-title":"Cardiovascular Drugs and Therapy"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108316_bb0840","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.brainres.2006.04.108","article-title":"Ameliorative effect of pioglitazone on seizure responses in genetically epilepsy-susceptible EL mice","volume":"1102","author":"Okada","year":"2006","journal-title":"Brain Research"},{"issue":"27","key":"10.1016\/j.pharmthera.2022.108316_bb0845","doi-asserted-by":"crossref","first-page":"16114","DOI":"10.1074\/jbc.270.27.16114","article-title":"Novel sequence determinants in peroxisome proliferator signaling","volume":"270","author":"Palmer","year":"1995","journal-title":"Journal of Biological Chemistry"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108316_bb0850","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/cas.12143","article-title":"Peroxisome proliferator-activated receptor-\u03b3 activation inhibits hepatocellular carcinoma cell invasion by upregulating plasminogen activator inhibitor-1","volume":"104","author":"Pang","year":"2013","journal-title":"Cancer Science"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108316_bb0855","doi-asserted-by":"crossref","first-page":"H2843","DOI":"10.1152\/ajpheart.01274.2004","article-title":"Epileptic seizures cause extended postictal cerebral vascular dysfunction that is prevented by HO-1 overexpression","volume":"288","author":"Parfenova","year":"2005","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108316_bb0860","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1158\/0008-5472.CAN-03-3924","article-title":"Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S -transferase gene by the peroxisome proliferator-activated receptor-\u03b3 and retinoid X receptor heterodimer","volume":"64","author":"Park","year":"2004","journal-title":"Cancer Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108316_bb0865","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0105-17.2017","article-title":"Hippocampal TNF\u03b1 signaling contributes to seizure generation in an infection-induced mouse model of limbic epilepsy","volume":"4","author":"Patel","year":"2017","journal-title":"ENeuro"},{"key":"10.1016\/j.pharmthera.2022.108316_bb0870","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/1691428","article-title":"Cannabis sativa L. and nonpsychoactive cannabinoids: their chemistry and role against oxidative stress, inflammation, and cancer","volume":"2018","author":"Pellati","year":"2018","journal-title":"BioMed Research International"},{"issue":"12","key":"10.1016\/j.pharmthera.2022.108316_bb0875","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/cns.13265","article-title":"Rosiglitazone polarizes microglia and protects against pilocarpine-induced status epilepticus","volume":"25","author":"Peng","year":"2019","journal-title":"CNS Neuroscience & Therapeutics"},{"key":"10.1016\/j.pharmthera.2022.108316_bb0880","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neuroscience.2020.10.026","article-title":"Rosiglitazone prevents autophagy by regulating Nrf2-antioxidant response element in a rat model of lithium-pilocarpine-induced status epilepticus","volume":"455","author":"Peng","year":"2021","journal-title":"Neuroscience"},{"issue":"39","key":"10.1016\/j.pharmthera.2022.108316_bb0885","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108316_bb0890","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.nbd.2014.08.011","article-title":"Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-\u03b3 agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson\u2019s disease","volume":"71","author":"Pisanu","year":"2014","journal-title":"Neurobiology of Disease"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108316_bb0895","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/0006-2952(91)90557-L","article-title":"Influence of chronic administration of valproate on ultrastructure and enzyme content of peroxisomes in rat liver and kidney. Oxidation of valproate by liver peroxisomes","volume":"41","author":"Ponchaut","year":"1991","journal-title":"Biochemical Pharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108316_bb0900","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1528-1167.2008.01901.x","article-title":"Fenofibrate, a peroxisome proliferator-activated receptor-\u03b1 agonist, exerts anticonvulsive properties","volume":"50","author":"Porta","year":"2009","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108316_bb0905","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1111\/epi.13863","article-title":"Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy","volume":"58","author":"Puligheddu","year":"2017","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108316_bb0910","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064541","article-title":"PPAR-alpha agonists as novel antiepileptic drugs: Preclinical findings","volume":"8","author":"Puligheddu","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108316_bb0915","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/cbf.3306","article-title":"Wnt\/\u03b2-catenin signalling pathway mediated aberrant hippocampal neurogenesis in kainic acid-induced epilepsy","volume":"35","author":"Qu","year":"2017","journal-title":"Cell Biochemistry and Function"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108316_bb0920","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology"},{"key":"10.1016\/j.pharmthera.2022.108316_bb0925","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.freeradbiomed.2018.08.014","article-title":"Role of GPx3 in PPAR\u03b3-induced protection against COPD-associated oxidative stress","volume":"126","author":"Reddy","year":"2018","journal-title":"Free Radical Biology & Medicine"},{"issue":"18","key":"10.1016\/j.pharmthera.2022.108316_bb0930","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1523\/JNEUROSCI.2751-17.2018","article-title":"Matrix metalloproteinase-mediated blood-brain barrier dysfunction in epilepsy","volume":"38","author":"Rempe","year":"2018","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108316_bb0935","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1046\/j.1528-1157.2002.47901.x","article-title":"Acetoacetate, acetone, and dibenzylamine (a contaminant in l-(+)-beta-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo","volume":"43","author":"Rho","year":"2002","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108316_bb0940","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/epi4.12376","article-title":"Is cannabidiol a drug acting on unconventional targets to control drug-resistant epilepsy?","volume":"5","author":"Rocha","year":"2020","journal-title":"Epilepsia Open"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108316_bb0945","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0165-6147(93)90005-5","article-title":"Therapeutic potential of excitatory amino acid antagonists: Channel blockers and 2,3-benzodiazepines","volume":"14","author":"Rogawski","year":"1993","journal-title":"Trends in Pharmacological Sciences"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108316_bb0950","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrn1430","article-title":"The neurobiology of antiepileptic drugs","volume":"5","author":"Rogawski","year":"2004","journal-title":"Nature Reviews Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108316_bb0955","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.seizure.2022.06.013","article-title":"Phosphatase and tensin homolog (PTEN) variants and epilepsy: A multicenter case series","volume":"100","author":"Ronzano","year":"2022","journal-title":"Seizure"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108316_bb0960","first-page":"1604","article-title":"Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: Possible implications for breast cancer therapy","volume":"60","author":"Rubin","year":"2000","journal-title":"Cancer Research"},{"issue":"18","key":"10.1016\/j.pharmthera.2022.108316_bb0965","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.3390\/ijms20184378","article-title":"Impact of PPAR-alpha polymorphisms\u2014The case of metabolic disorders and atherosclerosis","volume":"20","author":"Ruscica","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2022.108316_bb0970","series-title":"Advances in Pharmacology","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/bs.apha.2017.03.004","article-title":"Cannabis pharmacology: The usual suspects and a few promising leads","volume":"Vol. 80","author":"Russo","year":"2017"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108316_bb0975","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0920-1211(94)00078-B","article-title":"Noradrenergic modulation of epileptiform activity in the hippocampus","volume":"20","author":"Rutecki","year":"1995","journal-title":"Epilepsy Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108316_bb0980","doi-asserted-by":"crossref","first-page":"45","DOI":"10.14581\/jer.14011","article-title":"Anti-kindling effect of bezafibrate, a peroxisome proliferator-activated receptors alpha agonist, in pentylenetetrazole induced kindling seizure model","volume":"4","author":"Saha","year":"2014","journal-title":"Journal of Epilepsy Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108316_bb0985","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.3892\/mmr.2015.3641","article-title":"Peroxisome proliferator-activated receptor-\u03b3 agonist inhibits the mammalian target of rapamycin signaling pathway and has a protective effect in a rat model of status epilepticus","volume":"12","author":"San","year":"2015","journal-title":"Molecular Medicine Reports"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108316_bb0990","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4103\/0976-9668.210016","article-title":"Neuroanatomical changes in brain structures related to cognition in epilepsy: An update","volume":"8","author":"Saniya","year":"2017","journal-title":"Journal of Natural Science, Biology and Medicine"},{"key":"10.1016\/j.pharmthera.2022.108316_bb0995","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.23","article-title":"MicroRNA-34a upregulation during seizure-induced neuronal death","volume":"3","author":"Sano","year":"2012","journal-title":"Cell Death & Disease"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108316_bb1000","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.2042-7158.2011.01366.x","article-title":"Role of PPARg2 transcription factor in thiazolidinedione-induced insulin sensitization","volume":"64","author":"Saraf","year":"2012","journal-title":"The Journal of Pharmacy and Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108316_bb1005","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.666958","article-title":"Reassessment of pioglitazone for Alzheimer\u2019s disease","volume":"15","author":"Saunders","year":"2021","journal-title":"Frontiers in Neuroscience"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108316_bb1010","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.2337\/db06-0263","article-title":"Adipose tissue","volume":"55","author":"Scherer","year":"2006","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108316_bb1015","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0887-8994(00)00145-4","article-title":"Mitochondrial activity in pompe\u2019s disease","volume":"23","author":"Selak","year":"2000","journal-title":"Pediatric Neurology"},{"issue":"2\u201303","key":"10.1016\/j.pharmthera.2022.108316_bb1020","first-page":"112","article-title":"Toxicity of pioglitazone on mitochondria isolated from brain and heart: An analysis for probable drug-induced neurotoxicity and cardiotoxicity","volume":"70","author":"Seydi","year":"2020","journal-title":"Drug Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108316_bb1025","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.brainresbull.2012.02.001","article-title":"Sub-chronic treatment with pioglitazone exerts anti-convulsant effects in pentylenetetrazole-induced seizures of mice: The role of nitric oxide","volume":"87","author":"Shafaroodi","year":"2012","journal-title":"Brain Research Bulletin"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108316_bb1030","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/bjc.2012.130","article-title":"PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice","volume":"106","author":"Shen","year":"2012","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.pharmthera.2022.108316_bb1035","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.expneurol.2016.08.006","article-title":"Regulation of brain PPARgamma2 contributes to ketogenic diet anti-seizure efficacy","volume":"287","author":"Simeone","year":"2017","journal-title":"Experimental Neurology"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108316_bb1040","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/epi.13809","article-title":"Synergistic protection against acute flurothyl-induced seizures by adjuvant treatment of the ketogenic diet with the type 2 diabetes drug pioglitazone","volume":"58","author":"Simeone","year":"2017","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108316_bb1045","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1096\/fj.00-0020com","article-title":"Thiazolidinediones (PPARgamma agonists) but not PPARalpha agonists increase IRS-2 gene expression in 3T3-L1 and human adipocytes","volume":"15","author":"Smith","year":"2001","journal-title":"FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108316_bb1050","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2337\/diabetes.47.4.507","article-title":"PPAR-gamma: Adipogenic regulator and thiazolidinedione receptor","volume":"47","author":"Spiegelman","year":"1998","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.pharmthera.2022.108316_bb1055","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11882-021-01022-x","article-title":"The role of PPAR-\u03b3 in allergic disease","volume":"21","author":"Stark","year":"2021","journal-title":"Current Allergy and Asthma Reports"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108316_bb1060","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pharmthera.2006.07.005","article-title":"Novel anticonvulsant drugs","volume":"113","author":"Stefan","year":"2007","journal-title":"Pharmacology & Therapeutics"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108316_bb1065","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.vetimm.2012.02.003","article-title":"Seizure activity in dogs is associated with enhanced TIMP-2 expression of microglia","volume":"146","author":"Stein","year":"2012","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"10.1016\/j.pharmthera.2022.108316_bb1070","article-title":"A systematic review of minor phytocannabinoids with promising neuroprotective potential","volume":"bph.15185","author":"Stone","year":"2020","journal-title":"British Journal of Pharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108316_bb1075","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ijdevneu.2008.01.009","article-title":"Peroxisome proliferator-activated receptor gamma agonist, rosiglitazone, suppresses CD40 expression and attenuates inflammatory responses after lithium pilocarpine-induced status epilepticus in rats","volume":"26","author":"Sun","year":"2008","journal-title":"International Journal of Developmental Neuroscience"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108316_bb1080","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuint.2006.03.020","article-title":"PPAR\u03b3 as a therapeutic target in central nervous system diseases","volume":"49","author":"Sundararajan","year":"2006","journal-title":"Neurochemistry International"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108316_bb1085","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1006\/bbrc.2001.5602","article-title":"Identification of a novel peroxisome proliferator-activated receptor (PPAR) \u03b3 promoter in man and transactivation by the nuclear receptor ROR\u03b11","volume":"287","author":"Sundvold","year":"2001","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108316_bb1090","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/j.1528-1167.2010.02654.x","article-title":"Polyunsaturated fatty acids and epilepsy: Polyunsaturated Fatty Acids and Epilepsy","volume":"51","author":"Taha","year":"2010","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108316_bb1095","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neures.2006.06.003","article-title":"Prostaglandin E2 produced by late induced COX-2 stimulates hippocampal neuron loss after seizure in the CA3 region","volume":"56","author":"Takemiya","year":"2006","journal-title":"Neuroscience Research"},{"issue":"20","key":"10.1016\/j.pharmthera.2022.108316_bb1100","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1128\/MCB.00436-07","article-title":"The nuclear hormone receptor peroxisome proliferator-activated receptor beta\/delta potentiates cell chemotactism, polarization, and migration","volume":"27","author":"Tan","year":"2007","journal-title":"Molecular and Cellular Biology"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108316_bb1105","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/cam4.1354","article-title":"Pioglitazone and bladder cancer risk: A systematic review and meta-analysis","volume":"7","author":"Tang","year":"2018","journal-title":"Cancer Medicine"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108316_bb1110","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1101\/gad.8.10.1224","article-title":"mPPAR gamma 2: Tissue-specific regulator of an adipocyte enhancer","volume":"8","author":"Tontonoz","year":"1994","journal-title":"Genes & Development"},{"issue":"21","key":"10.1016\/j.pharmthera.2022.108316_bb1115","doi-asserted-by":"crossref","first-page":"18785","DOI":"10.1074\/jbc.M206999200","article-title":"Thiazolidinediones block fatty acid release by inducing glyceroneogenesis in fat cells","volume":"278","author":"Tordjman","year":"2003","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108316_bb1120","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1476-5381.2012.02140.x","article-title":"Carbamazepine directly inhibits adipocyte differentiation through activation of the ERK 1\/2 pathway: Anti-adipogenic effect of carbamazepine","volume":"168","author":"Turpin","year":"2013","journal-title":"British Journal of Pharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108316_bb1125","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4103\/2231-4040.90879","article-title":"The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases","volume":"2","author":"Tyagi","year":"2011","journal-title":"Journal of Advanced Pharmaceutical Technology & Research"},{"issue":"17","key":"10.1016\/j.pharmthera.2022.108316_bb1130","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1097\/WNR.0b013e3282f16df6","article-title":"Ablation of p27 enhance kainate-induced seizure and hippocampal degeneration","volume":"18","author":"Ueyama","year":"2007","journal-title":"Neuroreport"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108316_bb1135","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s13311-014-0304-z","article-title":"Neuroprotective properties of cannabigerol in Huntington\u2019s disease: Studies in R6\/2 mice and 3-nitropropionate-lesioned mice","volume":"12","author":"Valdeolivas","year":"2015","journal-title":"Neurotherapeutics: The Journal of the American Society for Experimental NeuroTherapeutics"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108316_bb1140","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/abbs\/gmx073","article-title":"Effects of cannabidiol interactions with Wnt\/\u03b2-catenin pathway and PPAR\u03b3 on oxidative stress and neuroinflammation in Alzheimer\u2019s disease","volume":"49","author":"Vall\u00e9e","year":"2017","journal-title":"Acta Biochimica et Biophysica Sinica"},{"key":"10.1016\/j.pharmthera.2022.108316_bb1145","doi-asserted-by":"crossref","first-page":"6986984","DOI":"10.1155\/2018\/6986984","article-title":"Peroxisomal Acyl-CoA oxidase type 1: Anti-inflammatory and anti-aging properties with a special emphasis on studies with LPS and argan oil as a model transposable to aging","volume":"2018","author":"Vamecq","year":"2018","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108316_bb1150","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.bbadis.2011.02.014","article-title":"PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation","volume":"1812","author":"Varga","year":"2011","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"issue":"12","key":"10.1016\/j.pharmthera.2022.108316_bb1155","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.tibs.2010.07.003","article-title":"Sirtuin regulation of mitochondria: Energy production, apoptosis, and signaling","volume":"35","author":"Verdin","year":"2010","journal-title":"Trends in Biochemical Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108316_bb1160","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10571-017-0554-5","article-title":"Roles of peroxisome proliferator-activated receptor gamma on brain and peripheral inflammation","volume":"38","author":"Villapol","year":"2018","journal-title":"Cellular and Molecular Neurobiology"},{"key":"10.1016\/j.pharmthera.2022.108316_bb1165","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuro.2014.03.004","article-title":"Perspectives on neuroinflammation and excitotoxicity: A neurotoxic conspiracy?","volume":"43","author":"Viviani","year":"2014","journal-title":"NeuroToxicology"},{"issue":"2\u20133","key":"10.1016\/j.pharmthera.2022.108316_bb1170","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0014-2999(97)01467-2","article-title":"Anticonvulsant effect of polyunsaturated fatty acids in rats, using the cortical stimulation model","volume":"341","author":"Voskuyl","year":"1998","journal-title":"European Journal of Pharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108316_bb1175","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/1074-5521(95)90045-4","article-title":"Peroxisome proliferator activated receptors: Transcriptional regulators of adipogenesis, lipid metabolism and more\u2026","volume":"2","author":"Wahli","year":"1995","journal-title":"Chemistry & Biology"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108316_bb1180","first-page":"1205","article-title":"Mutations and phenotype in isolated glycerol kinase deficiency","volume":"58","author":"Walker","year":"1996","journal-title":"American Journal of Human Genetics"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108316_bb1185","doi-asserted-by":"crossref","first-page":"27618","DOI":"10.1038\/srep27618","article-title":"Localization of PPAR isotypes in the adult mouse and human brain","volume":"6","author":"Warden","year":"2016","journal-title":"Scientific Reports"},{"issue":"13","key":"10.1016\/j.pharmthera.2022.108316_bb1190","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1056\/NEJM199803263381314","article-title":"Hepatic Dysfunction Associated with Troglitazone","volume":"338","author":"Watkins","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108316_bb1195","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1124\/mol.59.5.1269","article-title":"Induction of differentiation in F9 cells and activation of peroxisome proliferator-activated receptor \u03b4 by valproic acid and its teratogenic derivatives","volume":"59","author":"Werling","year":"2001","journal-title":"Molecular Pharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108316_bb1200","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/jm990554g","article-title":"The PPARs: From orphan receptors to drug discovery","volume":"43","author":"Willson","year":"2000","journal-title":"Journal of Medicinal Chemistry"},{"issue":"12","key":"10.1016\/j.pharmthera.2022.108316_bb1205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144806","article-title":"Rosiglitazone suppresses in vitro seizures in hippocampal slice by inhibiting presynaptic glutamate release in a model of temporal lobe epilepsy","volume":"10","author":"Wong","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2022.108316_bb1210","series-title":"The global burden of disease: 2004 update. 146","author":"World Health Organization","year":"2008"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108316_bb1215","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00041433-200402000-00009","article-title":"Modulation of immune and inflammatory responses by dietary lipids","volume":"15","author":"Wu","year":"2004","journal-title":"Current Opinion in Lipidology"},{"key":"10.1016\/j.pharmthera.2022.108316_bb1220","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/417646","article-title":"Peroxisome proliferator-activated receptors protect against apoptosis via 14-3-3","volume":"2010","author":"Wu","year":"2010","journal-title":"PPAR Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108316_bb1225","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1172\/JCI1244","article-title":"PPARgamma induces the insulin-dependent glucose transporter GLUT4 in the absence of C\/EBPalpha during the conversion of 3T3 fibroblasts into adipocytes","volume":"101","author":"Wu","year":"1998","journal-title":"The Journal of Clinical Investigation"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108316_bb1230","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1210\/me.2015-1301","article-title":"Loss of fatty acid binding protein 4\/aP2 reduces macrophage inflammation through activation of SIRT3","volume":"30","author":"Xu","year":"2016","journal-title":"Molecular Endocrinology (Baltimore, Md.)"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108316_bb1235","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1172\/JCI33009","article-title":"Leptin inhibits 4-aminopyridine- and pentylenetetrazole-induced seizures and AMPAR-mediated synaptic transmission in rodents","volume":"118","author":"Xu","year":"2008","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2022.108316_bb1240","article-title":"Arachidonic acid metabolism controls macrophage alternative activation through regulating oxidative phosphorylation in PPAR\u03b3 dependent manner","volume":"12","author":"Xu","year":"2021","journal-title":"Frontiers in Immunology"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2022.108316_bb1245","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0014-2999(94)90387-5","article-title":"Essential fatty acid preparation (SR-3) raises the seizure threshold in rats","volume":"254","author":"Yehuda","year":"1994","journal-title":"European Journal of Pharmacology"},{"issue":"11","key":"10.1016\/j.pharmthera.2022.108316_bb1250","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJMra041001","article-title":"Thiazolidinediones","volume":"351","author":"Yki-J\u00e4rvinen","year":"2004","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2022.108316_bb1255","doi-asserted-by":"crossref","DOI":"10.11131\/2015\/101188","article-title":"Peroxisome proliferator-activated receptors features, functions, and future","volume":"2","author":"Youssef","year":"2015","journal-title":"Nuclear Receptor Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108316_bb1260","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/cvr\/cvn172","article-title":"Decrease of peroxisome proliferator-activated receptor delta expression in cardiomyopathy of streptozotocin-induced diabetic rats","volume":"80","author":"Yu","year":"2008","journal-title":"Cardiovascular Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108316_bb1265","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1002\/hep.23550","article-title":"Inhibitory role of peroxisome proliferator-activated receptor gamma in hepatocarcinogenesis in mice and in vitro","volume":"51","author":"Yu","year":"2010","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"34","key":"10.1016\/j.pharmthera.2022.108316_bb1270","doi-asserted-by":"crossref","first-page":"21181","DOI":"10.1074\/jbc.272.34.21181","article-title":"Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2","volume":"272","author":"Yu","year":"1997","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108316_bb1275","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.brainres.2008.01.047","article-title":"Activation of cerebral peroxisome proliferator-activated receptors gamma exerts neuroprotection by inhibiting oxidative stress following pilocarpine-induced status epilepticus","volume":"1200","author":"Yu","year":"2008","journal-title":"Brain Research"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108316_bb1280","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.bcp.2013.02.015","article-title":"SIRT1 inhibits NADPH oxidase activation and protects endothelial function in the rat aorta: Implications for vascular aging","volume":"85","author":"Zarzuelo","year":"2013","journal-title":"Biochemical Pharmacology"},{"issue":"16","key":"10.1016\/j.pharmthera.2022.108316_bb1285","doi-asserted-by":"crossref","first-page":"7541","DOI":"10.1073\/pnas.89.16.7541","article-title":"Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase\/3-hydroxyacyl-CoA dehydrogenase","volume":"89","author":"Zhang","year":"1992","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108316_bb1290","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1172\/JCI115980","article-title":"Mitochondrial oxidative stress after carbon monoxide hypoxia in the rat brain","volume":"90","author":"Zhang","year":"1992","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2022.108316_bb1295","article-title":"Cmah deficiency may lead to age-related hearing loss by influencing miRNA-PPAR mediated signaling pathway","volume":"7","author":"Zhang","year":"2019","journal-title":"PeerJ"},{"key":"10.1016\/j.pharmthera.2022.108316_bb1300","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.neuroscience.2017.10.024","article-title":"CD36 deficiency suppresses epileptic seizures","volume":"367","author":"Zheng","year":"2017","journal-title":"Neuroscience"},{"issue":"11","key":"10.1016\/j.pharmthera.2022.108316_bb1305","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.4161\/auto.24135","article-title":"After the banquet: Mitochondrial biogenesis, mitophagy, and cell survival","volume":"9","author":"Zhu","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.pharmthera.2022.108316_bb1310","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3389\/fncel.2017.00377","article-title":"Neuronal nitric oxide synthase contributes to PTZ kindling epilepsy-induced hippocampal endoplasmic reticulum stress and oxidative damage","volume":"11","author":"Zhu","year":"2017","journal-title":"Frontiers in Cellular Neuroscience"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108316_bb1315","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.bbalip.2007.01.007","article-title":"Peroxisome proliferator-activated receptor structures: Ligand specificity, molecular switch and interactions with regulators","volume":"1771","author":"Zoete","year":"2007","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"},{"key":"10.1016\/j.pharmthera.2022.108316_bb1320","doi-asserted-by":"crossref","DOI":"10.1016\/j.ntt.2021.107057","article-title":"Antiepileptic drugs lamotrigine and valproate differentially affect neuronal maturation in the developing chick embryo, yet with PAX6 as a potential common mediator","volume":"90","author":"Zosen","year":"2022","journal-title":"Neurotoxicology and Teratology"},{"issue":"12","key":"10.1016\/j.pharmthera.2022.108316_bb1325","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1158\/2159-8290.CD-19-0270","article-title":"Polyunsaturated fatty acids from astrocytes activate PPAR\u03b3 signaling in cancer cells to promote brain metastasis","volume":"9","author":"Zou","year":"2019","journal-title":"Cancer Discovery"},{"issue":"22","key":"10.1016\/j.pharmthera.2022.108316_bb1330","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1111\/bph.13320","article-title":"Valproic acid protects against haemorrhagic shock-induced signalling changes via PPAR\u03b3 activation in an in vitro model","volume":"172","author":"Zuckermann","year":"2015","journal-title":"British Journal of Pharmacology"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725822002108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725822002108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:26:03Z","timestamp":1759011963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725822002108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":266,"alternative-id":["S0163725822002108"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108316","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is the peroxisome proliferator-activated receptor gamma a putative target for epilepsy treatment? Current evidence and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108316","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108316"}}